Versant Capital Management, Inc - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$545
+54.0%
62
+342.9%
0.00%
Q2 2023$35414
+16.7%
0.00%
Q3 2021$0120.0%0.00%
Q2 2021$0120.0%0.00%
Q1 2021$0120.0%0.00%
Q4 2020$0120.0%0.00%
Q3 2020$0120.0%0.00%
Q2 2020$0120.0%0.00%
Q1 2020$0120.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders